Protara Therapeutics, Inc. (TARA) Financials

TARA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 79.0 million 10.6 million
2023-09-30 88.5 million 11.5 million
2023-06-30 95.1 million 9.9 million
2023-03-31 106.4 million 11.6 million

TARA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -8.7 million 1.5 million
2023-09-30 128000 1.4 million
2023-06-30 -9.4 million 1.6 million
2023-03-31 -12.9 million 1.6 million

TARA Net Income

No data available :(

TARA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 65.6 million - 5.5 million
2023-09-30 74.0 million - 5.7 million
2023-06-30 80.4 million - 5.9 million
2023-03-31 86.6 million - 6.2 million

TARA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 11.4 million
2023-09-30 11.3 million
2023-06-30 11.3 million
2023-03-31 11.3 million

TARA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 6.4 million 4.7 million 107000
2023-09-30 37000 6.2 million 4.5 million -
2023-06-30 2000 7.2 million 4.9 million -
2023-03-31 6000 5.1 million 4.6 million -

TARA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 107000
2023-09-30 - 107000
2023-06-30 - 420000
2023-03-31 - 77000

TARA

Price: $2.89

52 week price:
1.04
5.24

Earnings Per Share: -3.57 USD

P/E Ratio: -0.45

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 2909

Market Capitalization: 32.5 million

Links: